Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / Training / Seminars and Symposia / Prognostic significance of change in mammographic density among ER+ breast cancer patients treated with tamoxifen

Prognostic significance of change in mammographic density among ER+ breast cancer patients treated with tamoxifen

Sarah Nyante, PhD, Postdoctoral Fellow, Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute
When Jan 24, 2014
from 01:00 PM to 02:00 PM
Where 2101G McGavran-Greenberg Hall
Add event to calendar iCal

Cancer Epidemiology Seminar